Literature DB >> 18940677

Variation in supportive care practices in hematopoietic cell transplantation.

Stephanie J Lee1, Claudia C Astigarraga, Mary Eapen, Andrew S Artz, Stella M Davies, Richard Champlin, Madan Jagasia, Nancy A Kernan, Fausto R Loberiza, Margaret Bevans, Robert J Soiffer, Steven Joffe.   

Abstract

Hematopoietic cell transplantation is an elective procedure that results in prolonged immune suppression and high treatment-related morbidity and mortality. Transplant centers and physicians use a variety of prophylaxis and monitoring strategies to prevent or minimize complications. Little is known about the variability in these practices. We conducted an international Internet-based survey of 526 physicians to describe the spectrum of supportive care practices employed. Consistency in pretransplant cardiac (96%) and pulmonary (95%) screening, informed consent documentation (93%), and use of antifungal prophylaxis (92%) was observed. Greater heterogeneity was seen in use of myelogenous growth factors, empiric antibiotic therapy, protective isolation procedures, posttransplant monitoring, and environmental and social restrictions. Although some practice differences were associated with physician characteristics and transplant type, most practice variation remained unexplained. These results suggest a need for well-designed observational and interventional studies to provide data about which supportive care practices improve outcomes. For practices proved to be beneficial, publication of guidelines and incorporation of monitoring into quality improvement initiatives may help standardize practices.

Entities:  

Mesh:

Year:  2008        PMID: 18940677      PMCID: PMC3304538          DOI: 10.1016/j.bbmt.2008.08.008

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  33 in total

1.  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10

2.  Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation.

Authors:  W H Krüger; R J Hornung; B Hertenstein; W V Kern; N Kröger; P Ljungman; A R Zander
Journal:  J Hematother Stem Cell Res       Date:  2001-12

3.  The meaning of translational research and why it matters.

Authors:  Steven H Woolf
Journal:  JAMA       Date:  2008-01-09       Impact factor: 56.272

4.  Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: a 10-year experience.

Authors:  J A Russell; A Chaudhry; K Booth; C Brown; R C Woodman; K Valentine; D Stewart; J D Ruether; B A Ruether; A R Jones; M J Coppes; T Bowen; R Anderson; M Bouchard; L Rallison; M Stotts; M C Poon
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

5.  The basis of informed consent for BMT patients.

Authors:  L H Jacoby; B Maloy; E Cirenza; W Shelton; T Goggins; J Balint
Journal:  Bone Marrow Transplant       Date:  1999-04       Impact factor: 5.483

6.  Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.

Authors:  K A Marr; K Seidel; M A Slavin; R A Bowden; H G Schoch; M E Flowers; L Corey; M Boeckh
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

7.  Isolation in blood and marrow transplantation.

Authors:  M Z Cohen; C Ley; A J Tarzian
Journal:  West J Nurs Res       Date:  2001-10       Impact factor: 1.967

8.  Mental disturbances during isolation in bone marrow transplant patients with leukemia.

Authors:  T Sasaki; R Akaho; H Sakamaki; H Akiyama; M Yoshino; K Hagiya; M Atsumi
Journal:  Bone Marrow Transplant       Date:  2000-02       Impact factor: 5.483

9.  The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.

Authors:  K Ohashi; J Tanabe; R Watanabe; T Tanaka; H Sakamaki; A Maruta; S Okamoto; N Aotsuka; K Saito; M Nishimura; H Oh; M Matsuzaki; S Takahashi; S Yonekura
Journal:  Am J Hematol       Date:  2000-05       Impact factor: 10.047

10.  Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.

Authors:  Apar Kishor Ganti; Stephanie J Lee; Julie M Vose; Marcel P Devetten; R Gregory Bociek; James O Armitage; Philip J Bierman; Lori J Maness; Elizabeth C Reed; Fausto R Loberiza
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

View more
  13 in total

Review 1.  Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation.

Authors:  Navneet S Majhail
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

2.  Acute myeloid leukemia in the real world: why population-based registries are needed.

Authors:  Gunnar Juliusson; Vladimir Lazarevic; Ann-Sofi Hörstedt; Oskar Hagberg; Martin Höglund
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

3.  Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Stephanie J Lee; Gwen Quinn; Heather Jim; Jongphil Kim; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-11       Impact factor: 5.742

4.  Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.

Authors:  William A Wood; Stephanie J Lee; Ruta Brazauskas; Zhiwei Wang; Mahmoud D Aljurf; Karen K Ballen; David K Buchbinder; Jason Dehn; Cesar O Freytes; Hillard M Lazarus; Charles F Lemaistre; Paulette Mehta; David Szwajcer; Steven Joffe; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-07       Impact factor: 5.742

5.  Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?

Authors:  Sarah Alexander; Michael Nieder; Danielle M Zerr; Brian T Fisher; Christopher C Dvorak; Lillian Sung
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

6.  Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum.

Authors:  Miguel-Angel Perales; William A Wood; Pere Barba; Linda J Burns; Mark R Litzow; Mark B Juckett; Krishna V Komanduri; Stephanie J Lee; Sean M Devlin; Luciano J Costa; Shakila Khan; Andrea King; Andreas Klein; Amrita Krishnan; Adriana Malone; Muhammad Mir; Carina Moravec; George Selby; Vivek Roy; Melissa Cochran; Melisa K Stricherz; Michael D Westmoreland
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-21       Impact factor: 5.742

7.  Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

Authors:  William A Wood; Ruta Brazauskas; Zhen-Huan Hu; Hisham Abdel-Azim; Ibrahim A Ahmed; Mahmoud Aljurf; Sherif Badawy; Amer Beitinjaneh; Biju George; David Buchbinder; Jan Cerny; Laurence Dedeken; Miguel Angel Diaz; Cesar O Freytes; Siddhartha Ganguly; Usama Gergis; David Gomez Almaguer; Ashish Gupta; Gregory Hale; Shahrukh K Hashmi; Yoshihiro Inamoto; Rammurti T Kamble; Kehinde Adekola; Tamila Kindwall-Keller; Jennifer Knight; Lalit Kumar; Yachiyo Kuwatsuka; Jason Law; Hillard M Lazarus; Charles LeMaistre; Richard F Olsson; Michael A Pulsipher; Bipin N Savani; Kirk R Schultz; Ayman A Saad; Matthew Seftel; Sachiko Seo; Thomas C Shea; Amir Steinberg; Keith Sullivan; David Szwajcer; Baldeep Wirk; Jean Yared; Agnes Yong; Jignesh Dalal; Theresa Hahn; Nandita Khera; Carmem Bonfim; Yoshiko Atsuta; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-19       Impact factor: 5.742

8.  Costs of pediatric allogeneic hematopoietic-cell transplantation.

Authors:  Navneet S Majhail; Jaya M Mothukuri; Margaret L Macmillan; Michael R Verneris; Paul J Orchard; John E Wagner; Daniel J Weisdorf
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

Review 9.  Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology.

Authors:  M J Rioth; J Warner; B N Savani; M Jagasia
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

10.  Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child.

Authors:  Christina K Ullrich; Angie Mae Rodday; Kristin Bingen; Mary Jo Kupst; Sunita K Patel; Karen L Syrjala; Lynnette L Harris; Christopher J Recklitis; Lisa Schwartz; Stella Davies; Eva C Guinan; Grace Chang; Joanne Wolfe; Susan K Parsons
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-05       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.